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An increasing amount of evidence  has been  accumulated (1-3)  which  in- 
dicates that the albumin  of the plasma is formed in the liver.  The fact that 
the  degree  of albumin  depression  correlates well with  the  severity of liver 
involvement in patients with  various types of liver disease (4)  is strong evi- 
dence in favor of such a concept.  In view of the significance of the metabolic 
and oncotic effects of the albumin level of the plasma in determining the course 
of patients with various  types of hypoproteinemla, it would appear to be of 
special importance to obtain information regarding albumin synthesis in these 
patients in an attempt to discover possible remediable defects.  Direct studies 
of albumin turnover have yielded some information, but the picture in cirrhosis 
and nephrosis is often obscured by continued loss of albumin in ascitic fluid 
or urine.  The therapeutic use of concentrated solutions of human albumin 
has made it even more difficult  to determine the rate of production of albumin 
and  to  evaluate the  changes  brought  about by such  therapy.  The  use  of 
radioactive and isotope techniques has not as yet been feasible.  Two other 
plasma  proteins,  fibrinogen and prothrombin,  also  have  been  shown  to  be 
formed by the liver (5, 6).  To this list it is now possible to add a fourth pro- 
tein appearing  in  the plasma  and  synthesized by the liver,  namely plasma 
esterase. 
The  possibility arose  that,  through  a  study in  various  hypoproteinemic 
states of the other proteins synthesized by the liver and their changes during 
therapy,  information could be  obtained regarding  the  general formation of 
proteins by the liver which might be applicable  to the problem of albumin 
synthesis. 
Of the group of liver proteins  the plasma esterase lends itself most readily to ac- 
curate estimation.  In addition, the regeneration  of this enzyme can be studied in 
various  pathological  states, following its destruction  by a  parenteral injection  of 
diisopropyl fluorophosphate  (DFP).  This  material  is an extremely  powerful and 
specific inhibitor  of the esterase group of enzymes.  Several observers (7, 8)  have 
demonstrated conclusively that these  enzymes are  irreversibly  destroyed  beth in 
~o  and in ~/vo by DFP.  Comroe, Todd, and Koelle (8), in connection with their 
use of this material in patients with myasthenia gravis, studied the regeneration  of 
plasma esterase following its destruction  by DFP.  Wescoe  (9) and Grob (10) have 
independently applied  this technique  to the study of patients  with  liver  disease. 
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A  decreased rate  of formation of the enzyme  was noted.  These results  correlated 
with the fact that the level of this enzyme in the plasma is markedly  depressed in 
patients with involvement of the liver (11, 12).  Other  workers (13, 14) have demon- 
strated  a  high concentration of a  non-specific esterase  in the liver,  similar  to that 
found in plasma.  The amount of this  enzyme in  the  liver is  depressed  following 
experimental liver injury (13).  These observations and others (15,  16)  demonstrate 
quite  conclusively that  this  enzyme is formed  in  the  liver. 
A close correlation between the plasma albumin level and the esterase  activity in 
various pathological states was pointed out  by Faber  (11).  Such a  correlation did 
not exist in various proteinurias in which he found the plasma albumin to be depressed 
considerably more than the esterase (17).  He offered as explanation that the amount 
of esterase lost in the urine in such patients, relative to albumin, was small and out 
of proportion  to  the  plasma  albumin-esterase  ratio. 
The present  report  represents  a  further  study of the  relationship  between 
plasma  albumin  and  esterase  in patients  with  liver disease,  with  special  em- 
phasis  on  the  effects  of albumin  therapy  on  the  formation  of these  plasma 
components.  In  addition,  the  regeneration  of  this  enzyme  under  various 
conditions  in  patients  with  the  nephrotic  syndrome was  investigated  and  a 
comparison was  attempted  with  the findings  in  the  presence  of a  damaged 
liver.  An indication of a  defect in esterase synthesis in certain patients with 
the nephrotic syndrome was observed which was quite  different from the de- 
fect  found  in  patients  with  liver  disease. 
Materials an~t Methods 
Data  reported  in  this  communication  were  obtained  from  thirty  patients  with 
infectious hepatitis, twenty patients with cirrhosis of the liver, and ten patients with 
the nephrotic syndrome who were admitted  to the Hospital or to the Out Patient 
Department  of  the  Rockefeller  Institute.  The  diagnosis  of cirrhosis  of  the  liver 
was dear from numerous liver function studies in addition to either the presence of 
ascites or direct visualization of biopsy sections of the liver.  The ages of the patients 
with cirrhosis of the liver ranged from 12 to 60.  The patients  with the nephrotic 
syndrome  all  showed  marked  albuminurla,  edema,  ascites,  and  plasma  albumin 
concentration  below 2  gm.  per  cent.  None of the  patients  showed a  true  lipoid 
nephrosis.  They all  showed evidence of glomerulonephritis  at  some time  in  their 
course.  Their ages were all below 14.  The normal controls included fourteen adults 
and  six  children below 12 years of age. 
Plasma esterase  was estimated by manometric measurement of the CO~ released 
from acetylcholine in bicarbonate buffer at pH 7.5.  From 0.1 to 0.3 cc. plasma was 
diluted to 3 cc. with a  buffer containing 0.03 ~  NaHCOs, 0.12 M NaC1,  and 0.04 M 
MgCI:.  This concentration of NaHCOa in the presence of 5 per cent COs  (in the 
gas phase) yields a pH of 7.5.  The 3 cc. of diluted plasma was placed in the main 
compartment  of Warburg flasks  and  acetylcholine  chloride  or bromide  (0.5  cc. of 
2.5 per cent solution in H20) was placed in the side arm.  The flasks were gassed with 
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with plasma.  After mixing, readings  were taken every 5 minutes for 30 minutes and 
corrected for the change occurring  in substrate and buffer alone.  The results were 
expressed in terms of cubic millimeters of CO~ released per 1 cc. of plasma per minute. 
Tributyrin also was used as substrate.  Inhibition experiments demonstrated  that 
the enzyme in the plasma splitting this substrate was inactivated by DFP and pro- 
stigmine in a  manner completely similar to the enzyme-splitting acetylcholine.  In 
addition,  the curve of regeneration of enzyme activity following DFP inactivation 
in ~/vo was the same with the two different  substrates.  It appeared that the same 
enzyme was measured in each case.  The non-specific nature of plasma esterase was 
dear.  Acetylcholine  was  used  as  substrate  in  the  following  experiments because 
it was hydrolyzed somewhat more readily and more accurate results could  be ob- 
tained. 
The enzyme was found to be extremely stable, and sera which had been stored for 
2  years at  0°C.  showed  the  same activity that  had  been found  initially.  Either 
serum or plasma could be used.  No evidence of inhibitors  of the  enzyme in  the 
plasma was ever found.  Bile salts and pigments did not inhibit the enzyme in con- 
centrations that exist in plasma.  Patients with cirrhosis  of the liver with or without 
jaundice showed  equally great depression  of esterase activity. 
A preparation of DFP in peanut oil was used for the in vivo destruction of plasma 
esterase.  0.04  rag.  per  kilo  of  body  weight  was  administered  intramuscularly. 
Plasma esterase was determined  the  day following administration and at periodic 
intervals thereafter.  The concentrated human serum albumin used therapeutically 
showed  no  esterase  activity. 
EXPEIt  rM~.NTAL 
The regeneration  of plasma esterase following administration  of DFP was 
studied in five individuals, two with the nephrotic syndrome, two with cirrhosis, 
and one normal (Fig. 1).  It was apparent that the rate of regeneration of the 
enzyme  differed  markedly  in  these  patients.  The  patients  with  cirrhosis 
showed a  very slow formation of the enzyme, while those with the nephrotic 
syndrome  synthesized  the  enzyme very  rapidly.  In  each  case  the  plasma 
esterase  level  approached  the  original  concentration  in  approximately  30 
days. 
A  close relationship appeared to exist between the rate of regeneration and 
the initial level of the enzyme in the plasma.  It seemed as if the level of the 
enzyme in the plasma reflected its rate of formation.  To test this hypothesis 
the  absolute  values  used  in  constructing  the  widely  divergent  regeneration 
curves of Fig. 1 were expressed in terms of percentage of the initial concentra- 
tion  of the enzyme.  When  these figures were plotted against time  (Fig.  2), 
very  similar  curves  were  obtained  for  each  of  the  five patients.  In  other 
words,  the  percentage  regeneration  of  the  enzyme was  the  same;  the  wide 
difference in the absolute rate of regeneration in the patients was evident from 
the initial level of the  enzyme in  the plasma.  The conclusion that  the  con- 
centration of enzyme appearing in the plasma at any one time is a  reflection 328  PI~S~ EST~.RASE ACTIVXTy 
of the rate of formation of the enzyme seems justified.  The major information 
regarding the synthesis of the enzyme can be obtained from its concentration 
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FIG. 1.  Curves showing the regeneration of plasma esterase following the administration 
of DFP in five individuals, two with the nephrotic syndrome, two with ch'rhosis  of the liver, 
and  one normal. 
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•Io.  2.  Curves  showing  the  plasma  esterase  regeneration  following DFP  with  values 
expressed in terms of percentage of the initial esterase concentration in the same five individ- 
uals shown in Fig. 1. 
in the plasma, and the difficult procedure of observing regeneration following 
DFP  is  unnecessary. 
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fectious Hepatitis.--The relation of the esterase level to the albumin concentra- 
tion of the plasma was studied in thirty patients with acute infectious hepatitis. 
This  disease  o~ered  the  ideal  opportunity for investigating  the  aberrations 
following acute liver damage.  Forty-four per cent of this group showed an 
albumin level below 4 gin. per cent ~hich returned to normal late in convales- 
cence.  All of the patients  showing abnormalities  in  the  amount  of plasma 
albumin also showed lowered esterase values (Table I).  The degree of lowering 
was  somewhat  difficult to  determine because  the  esterase  values  tended  to 
rise above normal during convalescence, and in order to determine the normal 
for each individual it was necessary to obtain values several months after the 
illness  had  terminated.  The  wide  variation  of  esterase  concentration  in 
healthy  individuals  (40  to  90  c,mm.  CO2) made  it  essential  to  obtain  the 
normal for each person.  A  depression of less  than  10  c.mm.  CO~  was  not 
considered significant.  Seventeen patients or 57 per cent of the thirty cases 
TABLE I 
Comparison of Plasma Esterase Depression in Infectious Hepatitis Patients with and 
without Abnormalities in Plasma Albumin 
Plasma albumin <4 gin. per cent.. 
Plasma albumin >4 gin. per cent 
(normal) ..................... 
No. of patients 
13 
17 
Per cent 
43 
57 
Per cent show- 
hag esterase 
depression > 10 
100 
46 
Average maxi- 
mal esterase 
depression 
c.~. 001 
28 
18 
showed no change in albumin concentration during the course of the disease. 
The esterase depression was considerably less in this group as shown in Table I. 
These observations demonstrate that  the plasma  esterase is more readily 
depressed in the presence of liver damage than the albumin level but that some 
relationship does exist.  The fact that the patients with a depression of plasma 
albumin were the most severely ill generally should be considered in evaluating 
this relationship.  Of greater significance was the finding that the depression 
of albumin  and  esterase occurred  at approximately the same  period  of  the 
disease.  Both showed a  delayed fall at  a  time when  the  symptoms of the 
illness were subsiding but prior to the rise in the globulin level (18).  Table 
II illustrates  this relation in  two  typical cases. 
Plasma Esterase Activity in Patients with Cirrhosis of the Liver and the Changes 
Occurring  w#h  Tkerapy.--In  patients  with cirrhosis of the liver the esterase 
depression was much more marked than in those with infectious hepatitis and 
the concentration was always below the normal range of 40 to 90 c.mm. CO2. 
Table III illustrates the results in eighteen patients with cirrhosis of the liver 
with  edema  and  ascites.  It  is  apparent  that  the  patients  with  the  lowest 330  PLASMA  ESTERASE  ACTIVITY 
albumin levels also had the most marked depression of the esterase concentra- 
tion.  Serial  determinations  of plasma esterase  over tong periods  of time in 
these patients demonstrated that  the esterase levels remained very constant. 
The patients often improved markedly on various types of therapy without 
any significant change in esterase activity.  It was only in those few patients 
who regained  the  ability  to  synthesize  normal amounts  of  plasma albumin 
TABLE H 
Comparison of Strial Determinations of Plasma Esterase and Albumin in Two Patients 
with Infectious Hepatitis 
Day of disease 
lOdaysbefore 
2 
5 
7 
12 
19 
27 
34 
56 
P|asma esterase 
c.~. CO~ 
68 
70 
52 
50 
68 
76 
75 
80 
72 
PIMma  albnmln I 
gin.  per ces# 
4.1 
4.3 
3.6 
3.7 
4.0 
4.2 
4.1 
4.1 
4.3 
Day of disease 
2 
3 
6 
10 
18 
25 
90 
Plasma esterase 
c.mm. COs 
6O 
63 
41 
32 
54 
74 
64 
Plasma albumin 
gra. per ~ttt 
4.0 
4.2 
3.5 
3.5 
4.0 
4.2 
4.1 
TABLE IH 
Comparative Resul~ of Plasma Eslerase Determinations in Patients  with Cirrhosis of the 
Liver with Di.~erent Concentrations of Serum Albumin 
(All Had Ascitts and F_&'ma) 
No. of patients  Albumin level  Average  esterase  level 
gra. per cent  c.m~a. COs 
Group A ...........................  13  2-3  22 
Group B ...........................  $  1-2  13 
that a  rise in esterase occurred.  Fig. 3  illustrates  the results, of serial deter- 
minations of serum albumin and esterase over a period of 18 months in a patient 
with  cirrhosis of the  liver.  The patient  received large amounts  of albumin 
intravenously,  which  brought  about  marked  clinical  improvement with  loss 
of ascites  and  edema  after  approximately 4  months  of  therapy.  However, 
he was unable  to  synthesize sufficient  albumin  to preserve permanently the 
normal serum albumin level provided by the injections.  The plasma esterase 
concentration remained constant throughout this period.  Afterapproximately 
12  months  of continued  general improvement, during  which  time he  put on 
considerable  body  weight,  he  finally  regained  the  capacity  to  maintain  a H.  O.  KUNKEL AND  S.  M.  WARD  331 
normal plasma  albumin  level.  At precisely the same  time he demonstrated 
the  capacity  to  synthesize  larger  amounts  of  plasma  esterase.  Following 
prolonged  supportive  therapy,  the  function  of  the  liver  finally  improved 
sufficiently to enable it to synthesize significant amounts of these two proteins. 
Two other patients with  cirrhosis of the liver who were treated  with  intra- 
venous liver extract for prolonged periods also regained their ability to pre- 
serve a  normal plasma albumin level as well as a  normal esterase level.  Ten 
patients with cirrhosis of the liver who have not regained the ability to form 
albumin in a  normal manner have shown no rise in plasma esterase although 
considerable  clinical  improvement  was  evident  in  the  majority.  In  every 
case the  serum  esterase remained  abnormal  as  long as  a  defect in albumin 
synthesis  persisted. 
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FiG.  3.  Curves showing the influence  of long continued intravenous  administrations of 
concentrated human serum albumin on the plasma albumin and esterase levels in a patient 
with cirrhosis of the liver. 
Plasma Esterase Aaivity in Patients with the Nephrotic Syndrome.--in direct 
contrast  to  the findings in patients with liver disease,  the esterase levels in 
patients with the nephrofic syndrome usually are higher than normal.  Table 
IV shows the average results from ten patients.  For purposes of comparison 
the results from normal  individuals  and  patients  with  cirrhosis of the  liver 
are  added.  Fig.  1  illustrates  the  rapid  regeneration  of  this  enzyme in two 
patients  with  the  nephrotic syndrome. 
In order to obtain information as to the reasons for the high values for plasma 
esterase  in  the  nephrotic  syndrome,  serial  determinations  were  carried  out 
over prolonged periods of time in such patients and variations during different 
phases of the disease were studied.  Fig. 4 illustrates the results of serial de- 
terminations of plasma esterase over a period of 3 months in two children with 
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Both patients had marked edema and ascites with severe albuminuria  and a serum 
albumin below 1 gin. per cent.  Neither patient received any specific  therapy.  In 
each case  the esterase values persisted above normal as long as  the patients were 
followed.  Patient 1 showed no evidence of improvement in his general condition 
TABLE IV 
Comparagve Amounts of Plasma Esterase in Patienl$ with the Nephroff¢ Syndrome, 
Cirrhosis of the Liver, and in Normal Controls 
No. of cases  Highest value  Lowest value  Average  value 
Nephrosis ......................  10  180  45  110 
Cirrhosis .......................  18  30  6  19 
Normal controls .................  20  91  42  65 
150 
140 
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PI(}. 4.  Curves showing tile results  of serial determinations  of plasma esterase  in two 
children with the nephrotic syndrome.  Patient 1 died, while Patient 2 developed a spon- 
taneous remission. 
and following a series of secondary infections finally died.  His esterase values showed 
a gradual decline reaching a minimum at the time of death.  Patient 2 also showed 
little change at first but suddenly, after approximately 3  months in the hospital, 
be developed a  diuresis with loss of  10 kilos of body weight and showed a  gradual 
rise in his plasma albumin level.  This improvement was  accompanied by a  rise in 
his plasma esterase which closely paralleled the rise in plasma albumin. H.  G.  KUNKEL  AND  S.  M.  WARD  333 
Similar increases of the enzyme also were observed in two other patients with 
nephrosis  who had  a  spontaneous  improvement in  their general  condition. 
The  rise  in  esterase  was  associated  with  an  increase  in  plasma  albumin 
despite persistent albuminuria. 
Effect of Albumin Therapy on the Esterase Level of the Plasma of Patients with 
the Nephrotic  Syndrome.--In  view of the rise of plasma esterase  following a 
spontaneous remission in patients with nephrosis,  it seemed advisable  to ob. 
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FIG. 5. Curves showing the effect  of intravenous albumin administration on the plasma 
esterase  level  in two patients  with the nephrotlc syndrome and two patients  with cirrhosis 
of  the  liver.  The arrows indicate  the  beginning  and end of therapy in  each case. 
serve the changes in the enzyme level produced  by various types of therapy. 
Determinations were carried  out serially  in two patients with the nephrotic 
syndrome who had very low  plasma albumin  levels  and who were  treated 
intravenously for approximately 30 days with an average  of twenty-four 25 
gin. units of concentrated human albumin (Fig. 5).  For purposes of compari- 
son, the results in two patients with cirrhosis of the liver who were similarly 
treated are charted.  The patients with the nephrotic syndrome had a striking 
rise in the concentration of esterase which began approximately 10 days after 
the onset of therapy.  This was of special interest because  the patients im- 334  PLASMA  ESTEP~_SE ACTIVITY 
proved considerably symptomatically with little other laboratory evidence of im- 
provement.  In  contrast  to  the patients  with  the  nephrotic  syndrome,  the 
patients with cirrhosis  of the liver showed very little variation in the plasma 
esterase level despite clinical  improvement. 
DISCUSSION 
The  chief  value of the  technique  of observing the regeneration  of plasma 
esterase following destruction by DFP was to demonstrate that the level of the 
enzyme in the plasma reflects its rate of formation.  Added significance may 
now be given to the  concentration  of the  enzyme in  the plasma  in various 
disease states.  The rapid regeneration of pla~m~ esterase in patients with the 
nephrotic syndrome as compared with the very slow regeneration in patients 
with cirrhosis  of the liver could be estimated  as well by the determinations of 
the level of the enzyme in the plasma as by the time-consuming technique using 
DFP. 
The low levels  of plasma esterase  in patients with severe liver disease ap- 
peared  to reflect the  inability  of  the  liver  to form normal  amounts  of this 
enzyme.  The liver's ability to form  another protein,  albumin, was similarly 
affected.  The delayed fall in these  two proteins following acute liver damage 
also suggested a formation defect.  The degree of depression  was proportional 
to the severity of the liver damage.  In  patients with cirrhosis  of the  liver 
long  sustained  therapy  is  necessary  before the  liver  regains  the  ability  to 
synthesize normal  amounts of albumin and  esterase.  The fact that the time 
necessary for this to occur was approximately the same for the two proteins 
is perhaps the best evidence of a  similar  formation.  In  these patients  there 
was little doubt about the site of the defect in protein synthesis.  The damaged 
liver  is  unable  to perform  this  function  adequately  regardless  of the  avail- 
ability of the essential  materials necessary for protein production. 
Numerous investigators have postulated a possible defect in protein synthesis 
by the liver in patients with the nephrotic syndrome (19-22).  The frequent 
observation of low plasma albumin levels in certain patients losing an amount 
of albumin that the normal person could readily replace has led to the belief 
that the primary defect may lie in the formation of albumin.  The application 
of the usual liver function tests, however, has not revealed any abnormality of 
the  liver  in  these  patients  (23).  Moreover,  since  the  formation  of plasma 
esterase is dependent on the condition of the liver, the high values found in 
patients with the nephrotic syndrome suggest that the liver is performing this 
function in a hypernormal fashion.  Although this evidence argues against a 
primary hepatic defect in protein formation in nephrosis,  it is of interest that 
albumin replace~nent  therapy leads to rises in esterase values to even higher 
levels, as is shown also during spontaneous remissions. 
It seems possible that the hypernormal levels of plasma esterase in nephrosis H.  G.  KUNKEL  AND  S.  M.  WARD  335 
reflect a  general response on the part of the liver to regenerate protein more 
rapidly as a result of the loss of albumin in the urine.  Further evidence for 
this hypothesis can be found in the high concentrations of fibrinogen found in 
the plasma  of  these  patients (24).  As  with  plasma esterase,  fibrinogen  is 
synthesized by the liver and is depressed in patients with severe liver involve- 
ment.  Electrophoretic studies have shown that certain of the alpha and beta 
globulins may rise in patients with nephrosis  (25).  It is not known whether 
all of these proteins are synthesized in the liver.  Immunological studies have 
also revealed  high concentrations of unusual proteins precipitating with the 
albumin fraction of the serum of these patients.  On the other hand, the gamma 
globulins  which  are generally considered  to be formed independently of the 
liver are actually depressed  (25); in liver disease they are increased  (26).  It 
would appear, therefore, that in patients with nephrosis the liver is functioning 
well and is stimulated by the albumin loss to form unusual amounts of the 
proteins which  it synthesizes.  The question  whether some  of the stimulus 
comes as a  response  to furnish proteins for the maintenance of the oncotic 
pressure  of the blood in the absence of albumin cannot be answered from the 
data at hand. 
The rapid rise  in  plasma esterase  concentration following spontaneous re- 
missions of the nephrotic syndrome or following therapy with albumin, when 
contrasted with the difficult alterability of the enzyme concentration in pa- 
tients with  cirrhosis,  demonstrates  quite  strikingly the  extreme  difference 
between these two disease states.  The fact that a rise in esterase  concentra- 
tion does occur in certain patients with the nephrotic syndrome demonstrates 
that a defect in esterase synthesis may be present.  This defect would appear to 
be very different from that existing  in patients with cirrhosis  of the liver. 
The rapidity of the esterase change following albumin therapy in patients with 
the nephrotic syndrome strongly suggests that the albumin supplies some factor 
which in the presence of an adequately functioning liver brings about increased 
synthesis of the enzyme.  The essential  factor may very well  be  albumin 
itself. 
The defect in esterase  formation may be similar  to that which is thought 
to exist in the synthesis of albumin in the severely ill nephrotic patient.  Since 
the synthesis of albumin is obscured  by the constant loss of albumin in the 
urine, study of the plasma esterase  system yields information concerning  a 
similar  protein, not lost in the urine to a  similar  extent, but the synthesis 
of which is altered by the conditions underlying the nephrotic syndrome.  It 
may be possible by this means to define the exact defect in protein formation 
that exists in these patients. 
The studies here reported appear to indicate that the liver is not primarily 
at fault but that certain essential materials which the liver needs for the syn- 
thesis of proteins in adequate amounts are lacking in certain patients with the 336  PLASMA ESTERASE ACTIVITY 
nephrofic syndrome.  If these  are  supplied,  the liver  can  readily form the 
necessary protein.  Evidence was presented that albumin administration aids 
in the synthesis of esterase by the liver.  It may well be that a certain amount 
of albumin must also be present in the blood and tissues for proper synthesis 
of albumin by the liver. 
SUMMARY 
By a study of plasma esterase in various hypoproteinemic states information 
was gained concerning the synthesis of a protein by the liver, which may be 
applicable  to  the  problem  of  albumin  synthesis.  Patients  with  infectious 
hepatitis and  cirrhosis  showed  defective formation of plasma  esterase  that 
paralleled the defect in albumin formation.  The defect could only be altered 
in  patients  with  cirrhosis  by  very  prolonged  therapy  indicating  that  liver 
function itself had to improve before the proteins could be formed in a normal 
manner.  Patients with the nephrotic syndrome showed a  normal or hyper- 
normal formation of plasma  esterase.  Following spontaneous remissions or 
the administration of albumin the esterase level showed a marked rise which 
was in direct contrast to the difficult alterability of the enzyme level in patients 
with  severe  liver  involvement.  It  is  suggested  that  the  defect  in  protein 
synthesis by patients with the nephrotic syndrome may be due to the lack of 
certain essential materials, one of which may be albumin itself, rather than 
to any abnormality in the liver. 
It is a pleasure to acknowledge  the aid of Dr. F. P. Chinard,  Dr. G. C. Cotzias, Dr. H. A. 
Eder, and Dr. O. J. Malta, and the helpful suggestions of Dr. D. D. Van Slyke. 
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